The G protein‐coupled receptors deorphanization landscape

&NA; G protein‐coupled receptors (GPCRs) are usually highlighted as being both the largest family of membrane proteins and the most productive source of drug targets. However, most of the GPCRs are understudied and hence cannot be used immediately for innovative therapeutic strategies. Besides, there are still around 100 orphan receptors, with no described endogenous ligand and no clearly defined function. The race to discover new ligands for these elusive receptors seems to be less intense than before. Here, we present an update of the various strategies employed to assign a function to these receptors and to discover new ligands. We focus on the recent advances in the identification of endogenous ligands with a detailed description of newly deorphanized receptors. Replication being a key parameter in these endeavors, we also discuss the latest controversies about problematic ligand‐receptor pairings. In this context, we propose several recommendations in order to strengthen the reporting of new ligand‐receptor pairs. Graphical abstract Figure. No caption available.

[1]  K. Su,et al.  A novel endothelin receptor type-B-like gene enriched in the brain. , 1997, Biochemical and biophysical research communications.

[2]  C. Langmead,et al.  Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants , 2016, PloS one.

[3]  K. Hansen,et al.  Pharmacological characterization of mouse GPRC6A, an L‐α‐amino‐acid receptor modulated by divalent cations , 2007, British journal of pharmacology.

[4]  J. Corbett,et al.  Neuronostatin inhibits glucose-stimulated insulin secretion via direct action on the pancreatic α-cell. , 2014, American journal of physiology. Endocrinology and metabolism.

[5]  C. Bowers History to the discovery of ghrelin. , 2012, Methods in enzymology.

[6]  C. Serhan,et al.  Resolvin D1 binds human phagocytes with evidence for proresolving receptors , 2010, Proceedings of the National Academy of Sciences.

[7]  Nitin J. Karandikar,et al.  The oligodendrocyte-specific G-protein coupled receptor GPR17 is a cell-intrinsic timer of myelination , 2009, Nature Neuroscience.

[8]  J. Violin,et al.  β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection , 2007 .

[9]  N. Bunnett,et al.  Protease-activated receptors: contribution to physiology and disease. , 2004, Physiological reviews.

[10]  Marc Parmentier,et al.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family , 2009, Pharmacological Reviews.

[11]  Arthur Christopoulos,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview , 2017, British journal of pharmacology.

[12]  R. Sunahara,et al.  Genetic evidence that β-arrestins are dispensable for the initiation of β2-adrenergic receptor signaling to ERK , 2017, Science Signaling.

[13]  Rob Leurs,et al.  Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. , 2007, Annual review of pharmacology and toxicology.

[14]  Gorjan Alagic,et al.  #p , 2019, Quantum information & computation.

[15]  이화영 X , 1960, Chinese Plants Names Index 2000-2009.

[16]  P. Bonaventure,et al.  Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 Receptor. , 2015, ACS medicinal chemistry letters.

[17]  M. Freissmuth,et al.  Recruitment of a Cytoplasmic Chaperone Relay by the A2A Adenosine Receptor , 2013, The Journal of Biological Chemistry.

[18]  Wei Liu,et al.  Successful Strategies to Determine High-Resolution Structures of GPCRs. , 2016, Trends in pharmacological sciences.

[19]  Seon-Young Kim,et al.  GPR171 expression enhances proliferation and metastasis of lung cancer cells , 2016, Oncotarget.

[20]  Charles N. Serhan,et al.  Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.

[21]  Adam J Pawson,et al.  International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands , 2013, Pharmacological Reviews.

[22]  Jeffrey A. Porter,et al.  A natural ligand for the orphan receptor GPR15 modulates lymphocyte recruitment to epithelia , 2017, Science Signaling.

[23]  R. Graham,et al.  Metalloprotease cleavage of the N terminus of the orphan G protein–coupled receptor GPR37L1 reduces its constitutive activity , 2016, Science Signaling.

[24]  A. Kuliopulos,et al.  Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development* , 2012, The Journal of Biological Chemistry.

[25]  S. Ferguson,et al.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. , 2001, Pharmacological reviews.

[26]  J. Krause,et al.  C5L2, a nonsignaling C5A binding protein. , 2003, Biochemistry.

[27]  O. Civelli,et al.  Orphan GPCR research , 2008, British journal of pharmacology.

[28]  K. Desai,et al.  Targeted Disruption of the β2 Adrenergic Receptor Gene* , 1999, The Journal of Biological Chemistry.

[29]  R. A. Hall,et al.  Fine-tuning of GPCR activity by receptor-interacting proteins , 2009, Nature Reviews Molecular Cell Biology.

[30]  T. Kenakin Biased signalling and allosteric machines: new vistas and challenges for drug discovery , 2012, British journal of pharmacology.

[31]  A. IJzerman,et al.  Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. , 2006, Trends in pharmacological sciences.

[32]  H. Bradshaw,et al.  A GPR18‐based signalling system regulates IOP in murine eye , 2013, British journal of pharmacology.

[33]  A. IJzerman,et al.  Human G protein-coupled receptor studies in Saccharomyces cerevisiae. , 2016, Biochemical pharmacology.

[34]  Peter M. Jones,et al.  The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasis , 2013, Diabetologia.

[35]  J. Reagan,et al.  Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35* , 2006, Journal of Biological Chemistry.

[36]  H. Schaller,et al.  Conserved amino acid sequence of a neuropeptide, the head activator, from coelenterates to humans , 1981, Nature.

[37]  C. Serhan,et al.  Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor , 1994, The Journal of experimental medicine.

[38]  C. Dahlgren,et al.  What Formyl Peptide Receptors, if Any, Are Triggered by Compound 43 and Lipoxin A4? , 2011, Scandinavian journal of immunology.

[39]  C. Dahlgren,et al.  Lipoxin A4 Metabolites/Analogues from Two Commercial Sources have No Effects on TNF‐α‐mediated Priming or Activation through the Neutrophil Formyl Peptide Receptors , 2009, Scandinavian journal of immunology.

[40]  A. Sher,et al.  Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 , 2005, The Journal of experimental medicine.

[41]  Kirsten B. Andersen,et al.  The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site , 2017, Scientific Reports.

[42]  E. Butcher,et al.  Orphan chemoattractant receptor GPR15 mediates dendritic epidermal T‐cell recruitment to the skin , 2014, European journal of immunology.

[43]  David E. Gloriam,et al.  Computer-Aided Discovery of Aromatic l-α-Amino Acids as Agonists of the Orphan G Protein-Coupled Receptor GPR139 , 2014, J. Chem. Inf. Model..

[44]  M. Trincavelli,et al.  The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptor , 2006, The EMBO journal.

[45]  J. Twizere,et al.  Activation of the Orphan G Protein–Coupled Receptor GPR27 by Surrogate Ligands Promotes β-Arrestin 2 Recruitment , 2017, Molecular Pharmacology.

[46]  T. Schöneberg,et al.  A tethered agonist within the ectodomain activates the adhesion G protein-coupled receptors GPR126 and GPR133. , 2014, Cell reports.

[47]  T. Horvath,et al.  FoxO 1 Target Gpr 17 Activates AgRP Neurons to Regulate Food Intake , 2016 .

[48]  Gebräuchliche Fertigarzneimittel,et al.  V , 1893, Therapielexikon Neurologie.

[49]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[50]  T. Schöneberg,et al.  The constitutive activity of the adhesion GPCR GPR114/ADGRG5 is mediated by its tethered agonist , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  R. Leurs,et al.  Quantitative expression profiling of G‐protein‐coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target , 2011, Pigment cell & melanoma research.

[52]  S. Mani,et al.  The metabolite GnRH-(1-5) inhibits the migration of immortalized GnRH neurons. , 2013, Endocrinology.

[53]  Mingyao Liu,et al.  Elimination of GPR146‐mediated antiviral function through IRF3/HES1‐signalling pathway , 2017, Immunology.

[54]  S. Hornemann,et al.  The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6 , 2016, Nature.

[55]  L. Quarles,et al.  Identification of a Novel Extracellular Cation-sensing G-protein-coupled Receptor* , 2005, Journal of Biological Chemistry.

[56]  S. Sentellas,et al.  Lack of activity of 15‐epi‐lipoxin A4 on FPR2/ALX and CysLT1 receptors in interleukin‐8‐driven human neutrophil function , 2013, Clinical and experimental immunology.

[57]  V. B. Lu,et al.  N-Arachidonyl Glycine Does Not Activate G Protein–Coupled Receptor 18 Signaling via Canonical Pathways , 2013, Molecular Pharmacology.

[58]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[59]  M. Parmentier,et al.  Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. , 2011, Cytokine & growth factor reviews.

[60]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[61]  D. Bechtold,et al.  GPR50 Interacts with TIP60 to Modulate Glucocorticoid Receptor Signalling , 2011, PloS one.

[62]  S. Mani,et al.  β-Arrestin 2 is a mediator of GnRH-(1-5) signaling in immortalized GnRH neurons. , 2013, Endocrinology.

[63]  Michelle M. Giddens,et al.  GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin , 2013, Proceedings of the National Academy of Sciences.

[64]  N. Ferreirós,et al.  Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄. , 2013, Biochemical pharmacology.

[65]  Ruben Abagyan,et al.  Identifying ligands at orphan GPCRs: current status using structure‐based approaches , 2016, British journal of pharmacology.

[66]  M. Duggan,et al.  Orphan seven transmembrane domain receptors: reversing pharmacology. , 1994, Trends in pharmacological sciences.

[67]  G. Milligan G protein‐coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35 , 2017, British journal of pharmacology.

[68]  T. Kohout,et al.  Regulation of Receptor Fate by Ubiquitination of Activated β2-Adrenergic Receptor and β-Arrestin , 2001, Science.

[69]  D. Im,et al.  GPR35 mediates lodoxamide‐induced migration inhibitory response but not CXCL17‐induced migration stimulatory response in THP‐1 cells; is GPR35 a receptor for CXCL17? , 2018, British journal of pharmacology.

[70]  Jonathan R. Tomshine,et al.  Conformational biosensors reveal GPCR signalling from endosomes , 2013, Nature.

[71]  Maria F. Sassano,et al.  A Pharmacological Organization of G Protein-coupled Receptors , 2012, Nature Methods.

[72]  H. Schiöth,et al.  G protein-coupled receptor deorphanizations. , 2013, Annual review of pharmacology and toxicology.

[73]  Dipendra K. Aryal,et al.  GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding , 2013, Proceedings of the National Academy of Sciences.

[74]  Z. Ou,et al.  The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer. , 2017, Biochemical and biophysical research communications.

[75]  S. Di,et al.  ProSAAS-Derived Peptides are Colocalized with Neuropeptide Y and Function as Neuropeptides in the Regulation of Food Intake , 2011, PloS one.

[76]  Kirsten B. Andersen,et al.  Novel Agonist Bioisosteres and Common Structure-Activity Relationships for The Orphan G Protein-Coupled Receptor GPR139 , 2016, Scientific Reports.

[77]  Marc Parmentier,et al.  Specific Recruitment of Antigen-presenting Cells by Chemerin, a Novel Processed Ligand from Human Inflammatory Fluids , 2003, The Journal of experimental medicine.

[78]  M. Smit,et al.  Cutting Edge: GPR35/CXCR8 Is the Receptor of the Mucosal Chemokine CXCL17 , 2015, The Journal of Immunology.

[79]  W. Zgrajka,et al.  Micromolar concentration of kynurenic acid in rat small intestine , 2008, Amino Acids.

[80]  H. Schaller,et al.  RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein‐coupled receptor 75 , 2006, British journal of pharmacology.

[81]  장윤희,et al.  Y. , 2003, Industrial and Labor Relations Terms.

[82]  L. Pardo,et al.  The Parkinson's disease‐associated GPR37 receptor‐mediated cytotoxicity is controlled by its intracellular cysteine‐rich domain , 2013, Journal of neurochemistry.

[83]  U. Bogdahn,et al.  Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug , 2015, Nature Communications.

[84]  M. Rask-Andersen,et al.  Trends in the exploitation of novel drug targets , 2011, Nature Reviews Drug Discovery.

[85]  Philippe Delagrange,et al.  The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization , 2006, The EMBO journal.

[86]  Xin Chen,et al.  Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65 , 2015, Nature.

[87]  R. Xu,et al.  GPR15-Mediated Homing Controls Immune Homeostasis in the Large Intestine Mucosa , 2013, Science.

[88]  Takao Shimizu,et al.  The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo , 2006, Pharmacological Reviews.

[89]  T. Saito,et al.  An evolutionarily conserved G-protein coupled receptor family, SREB, expressed in the central nervous system. , 2000, Biochemical and biophysical research communications.

[90]  W. Samson,et al.  Evidence for an interaction of neuronostatin with the orphan G protein-coupled receptor, GPR107. , 2012, American journal of physiology. Regulatory, integrative and comparative physiology.

[91]  R. Jockers,et al.  Alternative drug discovery approaches for orphan GPCRs. , 2008, Drug discovery today.

[92]  H. Biebermann,et al.  Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83 , 2016, PloS one.

[93]  Atsushi Inoue,et al.  Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. , 2006, Biochemical and biophysical research communications.

[94]  Yunpeng Wu,et al.  GPRC6A mediates the effects of L-arginine on insulin secretion in mouse pancreatic islets. , 2012, Endocrinology.

[95]  S. Mani,et al.  GnRH-(1-5) transactivates EGFR in Ishikawa human endometrial cells via an orphan G protein-coupled receptor. , 2014, Molecular endocrinology.

[96]  G. Milligan,et al.  Interactions between the Mas-Related Receptors MrgD and MrgE Alter Signalling and Trafficking of MrgD , 2006, Molecular Pharmacology.

[97]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[98]  T. Hökfelt,et al.  Distribution of an orphan G-protein coupled receptor (JP05) mRNA in the human brain , 2001, Brain Research.

[99]  T. Schöneberg,et al.  Gpr126 Functions in Schwann Cells to Control Differentiation and Myelination via G-Protein Activation , 2013, The Journal of Neuroscience.

[100]  H. Baba,et al.  Cloning of a G‐protein‐coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells , 2004, Cancer science.

[101]  G Vassart,et al.  Selective amplification and cloning of four new members of the G protein-coupled receptor family. , 1989, Science.

[102]  R. Jockers,et al.  Techniques for the discovery of GPCR-associated protein complexes. , 2013, Methods in enzymology.

[103]  D. Attwell,et al.  G protein‐coupled receptor 37‐like 1 modulates astrocyte glutamate transporters and neuronal NMDA receptors and is neuroprotective in ischemia , 2017, Glia.

[104]  T. Schöneberg,et al.  The Adhesion GPCR GPR126 Has Distinct, Domain-Dependent Functions in Schwann Cell Development Mediated by Interaction with Laminin-211 , 2015, Neuron.

[105]  E. Kostenis,et al.  The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl Leukotrienes , 2017, Molecular Pharmacology.

[106]  Bryan L Roth,et al.  Discovery of new GPCR ligands to illuminate new biology. , 2017, Nature chemical biology.

[107]  S. Rees,et al.  Screening β-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein–Coupled Receptors , 2013, Journal of biomolecular screening.

[108]  Richard R. Neubig,et al.  International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List , 2005, Pharmacological Reviews.

[109]  S. Woods,et al.  The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms , 2013, Nature Communications.

[110]  T. Benned-Jensen,et al.  Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants , 2010, British journal of pharmacology.

[111]  J. Brenchley,et al.  Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors , 2015, Journal of Virology.

[112]  C. J. Hutchings,et al.  Opportunities for therapeutic antibodies directed at G-protein-coupled receptors , 2017, Nature Reviews Drug Discovery.

[113]  Kirstie A. Cummings,et al.  The BigLEN-GPR171 Peptide Receptor System Within the Basolateral Amygdala Regulates Anxiety-Like Behavior and Contextual Fear Conditioning , 2017, Neuropsychopharmacology.

[114]  A. Stamford,et al.  Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. , 2000, Biochemical pharmacology.

[115]  Paul A. Insel,et al.  G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs? , 2018, Molecular Pharmacology.

[116]  T. Schöneberg,et al.  Identification of the tethered peptide agonist of the adhesion G protein-coupled receptor GPR64/ADGRG2. , 2015, Biochemical and biophysical research communications.

[117]  T. Schöneberg,et al.  Progress in demystification of adhesion G protein-coupled receptors , 2013, Biological chemistry.

[118]  M. Trincavelli,et al.  The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain Repair , 2008, PloS one.

[119]  R. Abagyan,et al.  RETRACTED ARTICLE: Orphan receptor ligand discovery by pickpocketing pharmacological neighbors , 2016, Nature Chemical Biology.

[120]  R. Jockers,et al.  Hunting for the function of orphan GPCRs – beyond the search for the endogenous ligand , 2015, British journal of pharmacology.

[121]  R. Meyer,et al.  GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactions. , 2009, Biochemistry.

[122]  Meryem Köse,et al.  Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17. , 2014, ACS medicinal chemistry letters.

[123]  K. Monk,et al.  G Protein-Coupled Receptors in Myelinating Glia. , 2016, Trends in pharmacological sciences.

[124]  A. Parrill,et al.  GPRC6A Mediates the Non-genomic Effects of Steroids* , 2010, The Journal of Biological Chemistry.

[125]  Veena P Menon,et al.  Discovery and SAR of a Series of Agonists at Orphan G Protein-Coupled Receptor 139. , 2011, ACS medicinal chemistry letters.

[126]  F. Chiodi,et al.  Toll-Like Receptor 3 Signalling UpRegulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD 4 ( + ) T Cells , 2014 .

[127]  Lakshmi A. Devi,et al.  Advancements in therapeutically targeting orphan GPCRs , 2015, Front. Pharmacol..

[128]  G. Milligan,et al.  Agonist activation of the G protein‐coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα13 and β‐arrestin‐2 , 2011, British journal of pharmacology.

[129]  D. Hay,et al.  Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25 , 2018, British journal of pharmacology.

[130]  M. Hollenberg,et al.  International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors , 2002, Pharmacological Reviews.

[131]  Daniel Schulz,et al.  Decoding Signaling and Function of the Orphan G Protein–Coupled Receptor GPR17 with a Small-Molecule Agonist , 2013, Science Signaling.

[132]  Michihiro Mieda The roles of orexins in sleep/wake regulation , 2017, Neuroscience Research.

[133]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[134]  Jilly F. Evans,et al.  Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7 , 2014, British journal of pharmacology.

[135]  Gunnar Kleinau,et al.  Identification of GPR83 as the receptor for the neuroendocrine peptide PEN , 2016, Science Signaling.

[136]  D. Donnelly,et al.  The GIP Receptor Displays Higher Basal Activity than the GLP-1 Receptor but Does Not Recruit GRK2 or Arrestin3 Effectively , 2014, PloS one.

[137]  T. Horvath,et al.  FoxO1 Target Gpr17 Activates AgRP Neurons to Regulate Food Intake , 2012, Cell.

[138]  T. Südhof,et al.  A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis , 2012, The EMBO journal.

[139]  Ryan T. Strachan,et al.  GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling , 2016, Cell.

[140]  M. Rudd,et al.  Structural Basis for Selectivity and Diversity in Angiotensin II Receptors , 2017, Nature.

[141]  D. Littman,et al.  Expression cloning of new receptors used by simian and human immunodeficiency viruses , 1997, Nature.

[142]  Maria F. Sassano,et al.  PRESTO-TANGO: an open-source resource for interrogation of the druggable human GPCR-ome , 2015, Nature Structural &Molecular Biology.

[143]  Samantha L. Hoopes,et al.  Vascular actions of 20-HETE. , 2015, Prostaglandins & other lipid mediators.

[144]  M. Hentzer,et al.  Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP+ and Rotenone Toxicity , 2016, Front. Cell. Neurosci..

[145]  G. Ferry,et al.  A Generic Approach for the Purification of Signaling Complexes That Specifically Interact with the Carboxyl-terminal Domain of G Protein-coupled Receptors*S , 2008, Molecular & Cellular Proteomics.

[146]  J. Kwak,et al.  Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. , 2003, Molecular pharmacology.

[147]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[148]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[149]  Kazuhiko Inoue,et al.  N-arachidonoyl glycine induces macrophage apoptosis via GPR18. , 2012, Biochemical and biophysical research communications.

[150]  T. K. Harden,et al.  Is GPR17 a P2Y/Leukotriene Receptor? Examination of Uracil Nucleotides, Nucleotide Sugars, and Cysteinyl Leukotrienes as Agonists of GPR17 , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[151]  Adam J Pawson,et al.  Gonadotropin-releasing hormone receptors. , 2004, Endocrine reviews.

[152]  C. J. Hutchings,et al.  Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment , 2014, mAbs.

[153]  GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids l-Tryptophan and l-Phenylalanine , 2015, Molecular Pharmacology.

[154]  C. Serhan,et al.  Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. , 2004, Prostaglandins & other lipid mediators.

[155]  A. Davenport,et al.  Evolving pharmacology of orphan GPCRs: IUPHAR Commentary , 2013, British journal of pharmacology.

[156]  T. Kenakin Cellular assays as portals to seven-transmembrane receptor-based drug discovery , 2009, Nature Reviews Drug Discovery.

[157]  A. Ardati,et al.  A new family of orphan G protein‐coupled receptors predominantly expressed in the brain 1 , 1998, FEBS letters.

[158]  C. Serhan,et al.  Resolvins , 2002, The Journal of Experimental Medicine.

[159]  W. Samson,et al.  Evidence for an interaction between proinsulin C-peptide and GPR146. , 2013, The Journal of endocrinology.

[160]  Arthur Christopoulos,et al.  A simple method for quantifying functional selectivity and agonist bias. , 2012, ACS chemical neuroscience.

[161]  R. Adan,et al.  AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. , 2001, Molecular endocrinology.

[162]  Thomas de Quincey [C] , 2000, The Works of Thomas De Quincey, Vol. 1: Writings, 1799–1820.

[163]  E. Butcher,et al.  A Mucosal and Cutaneous Chemokine Ligand for the Lymphocyte Chemoattractant Receptor GPR15 , 2017, Front. Immunol..

[164]  M. Glass,et al.  GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to N-Arachidonoyl Glycine , 2016, PeerJ.

[165]  R. Takahashi,et al.  Pael‐R is accumulated in Lewy bodies of Parkinson's disease , 2004, Annals of neurology.

[166]  Bryan L Roth,et al.  Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily* , 2015, The Journal of Biological Chemistry.

[167]  Albert C. Pan,et al.  The Dynamic Process of β2-Adrenergic Receptor Activation , 2013, Cell.

[168]  G. Milligan Orthologue selectivity and ligand bias: translating the pharmacology of GPR35. , 2011, Trends in pharmacological sciences.

[169]  S. Tenzer,et al.  Cell Type-Specific Tandem Affinity Purification of the Mouse Hippocampal CB1 Receptor-Associated Proteome. , 2016, Journal of proteome research.

[170]  J. Lupski,et al.  Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. , 2014, The New England journal of medicine.

[171]  R. Jockers,et al.  Do orphan G‐protein‐coupled receptors have ligand‐independent functions? , 2006, EMBO reports.

[172]  T. Kenakin Functional Selectivity and Biased Receptor Signaling , 2011, Journal of Pharmacology and Experimental Therapeutics.

[173]  T. Schöneberg,et al.  Activation of Adhesion G Protein-coupled Receptors , 2017, The Journal of Biological Chemistry.

[174]  H. Schaller,et al.  The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37 , 2006, Journal of Cell Science.

[175]  B. Monsarrat,et al.  Purification and Identification of G Protein-coupled Receptor Protein Complexes under Native Conditions*S , 2007, Molecular & Cellular Proteomics.

[176]  S. Ikeda,et al.  Inhibition of N-Type Calcium Channels by Activation of GPR35, an Orphan Receptor, Heterologously Expressed in Rat Sympathetic Neurons , 2008, Journal of Pharmacology and Experimental Therapeutics.

[177]  A. Ferguson,et al.  Neuronostatin Encoded by the Somatostatin Gene Regulates Neuronal, Cardiovascular, and Metabolic Functions* , 2008, Journal of Biological Chemistry.

[178]  Yunpeng Wu,et al.  GPRC6A mediates responses to osteocalcin in β‐cells in vitro and pancreas in vivo , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[179]  Kirsten B. Andersen,et al.  The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), α-, and β-melanocyte stimulating hormone (α-MSH, and β-MSH), and the conserved core motif HFRW , 2017, Neurochemistry International.

[180]  M. Mezei,et al.  Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake , 2016, Science Signaling.

[181]  Hans Clevers,et al.  Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling , 2011, Nature.

[182]  Christopher Southan,et al.  The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors , 2015, British journal of pharmacology.

[183]  G. Fitzgerald,et al.  'I. , 2019, Australian journal of primary health.

[184]  Miss A.O. Penney (b) , 1974, The New Yale Book of Quotations.

[185]  F. Chiodi,et al.  Toll-Like Receptor 3 Signalling Up-Regulates Expression of the HIV Co-Receptor G-Protein Coupled Receptor 15 on Human CD4+ T Cells , 2014, PloS one.

[186]  J. Wess,et al.  Lack of beta-arrestin signaling in the absence of active G proteins , 2018, Nature Communications.

[187]  J. Wahren,et al.  C‐peptide and long‐term complications of diabetes , 2011, Pediatric diabetes.

[188]  J. Violin,et al.  Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. , 2007, The Journal of clinical investigation.

[189]  H. Rang The receptor concept: pharmacology's big idea , 2006, British journal of pharmacology.

[190]  R. Lefkowitz,et al.  β-Arrestins and Cell Signaling , 2007 .

[191]  Liaoyuan A. Hu,et al.  Identification of Surrogate Agonists and Antagonists for Orphan G-Protein-Coupled Receptor GPR139 , 2009, Journal of biomolecular screening.

[192]  J. Konkel,et al.  Transforming Growth Factor‐&bgr; Signaling in Regulatory T Cells Controls T Helper‐17 Cells and Tissue‐Specific Immune Responses , 2017, Immunity.

[193]  Ryan T. Strachan,et al.  Regulation of Beta-2-Adrenergic Receptor Function by Conformationally Selective Single-domain Intrabodies , 2013 .

[194]  J. Falck,et al.  20-HETE Signals Through G-Protein–Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension , 2017, Circulation research.

[195]  G. Sumara,et al.  Endocrine Regulation of Male Fertility by the Skeleton , 2011, Cell.

[196]  N. Hattori,et al.  An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.

[197]  M. Neurath,et al.  Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo , 2015, Gut.

[198]  David E. Gloriam,et al.  Trends in GPCR drug discovery: new agents, targets and indications , 2017, Nature Reviews Drug Discovery.

[199]  R. Lefkowitz,et al.  Direct Binding of Activated c-Src to the β3-Adrenergic Receptor Is Required for MAP Kinase Activation* , 2000, The Journal of Biological Chemistry.

[200]  R. Lefkowitz,et al.  β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7 , 2009, Proceedings of the National Academy of Sciences.

[201]  Aaron Naatz,et al.  Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells. , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.